Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HaemaLogiX Ltd logo — Focusing on the development and commercialisation of novel i...

HaemaLogiX Ltd

Focusing on the development and commercialisation of novel immuno-oncology and immune-therapies.

Founded 2014 Australia Australia 7 employees Venture round Total: $10.00M Biotechnology, Health Care +1

General Information

Company Name HaemaLogiX Ltd
Founded Year 2014
Location Australia Australia
Founders / Decision Makers
Team member
Employees 7
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with HaemaLogiX Ltd. To contact HaemaLogiX Ltd, visit haemalogix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About HaemaLogiX Ltd

HaemaLogiX Ltd is a biotechnology and healthcare startup founded in 2014 in Australia. The company focuses on the development and commercialization of novel immuno-oncology and immune-therapies, with a mission to improve the quality of life for patients suffering from blood cancers and autoimmune diseases. HaemaLogiX is currently engaged in several inter-related research and clinical development projects aimed at validating antigen targets and products. The latest significant milestone for HaemaLogiX was a $10.00M Venture Round investment on 08 September 2021. The investment was led by Platinum Asset Management, a prominent player in the venture capital arena. HaemaLogiX's commitment to pioneering advancements in immuno-oncology and immune-therapies, combined with its recent substantial investment, positions the company for notable growth and potential breakthroughs in the treatment of blood cancers and autoimmune diseases.

Taxonomy: immuno-oncology, immune-therapies, blood cancers, autoimmune diseases, novel drug targets, antigen targets, multiple myeloma, lymphoma, Waldenstroms macroglobulinemia, antibodies, CAR-T cells, clinical development, proof of concept, investor returns, risk mitigation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $10.00M 2
Platinum Asset Management Cicada Innovations
Platinum Asset Management, Cicada Innovations
08 Sep 2021

HaemaLogiX Ltd Alternatives & Competitors

HaemaLogiX Ltd vs
Apitope
Apitope Belgium

Develops drugs for treatments of allergic diseases

Series B
1 employees
Biotechnology, Health Care
HaemaLogiX Ltd vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
157 employees
Biotechnology, Health Care
HaemaLogiX Ltd vs
Cellestia Biotech
Cellestia Biotech Switzerland

Cellestia develops targeted therapies for cancer patients with no other options, including orphan ca...

Non Equity Assistance
15 employees
Biopharma, Biotechnology

FAQ About HaemaLogiX Ltd

Focusing on the development and commercialisation of novel immuno-oncology and immune-therapies.
HaemaLogiX Ltd was founded in 2014.
HaemaLogiX Ltd is headquartered in Australia.
HaemaLogiX Ltd operates in Biotechnology, Health Care and Life Sciences. Its work centres on immuno-oncology, immune-therapies, blood cancers and autoimmune diseases.
HaemaLogiX Ltd has approximately 7 employees.
HaemaLogiX Ltd has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Venture round.
Top alternatives and competitors to HaemaLogiX Ltd include Apitope, Tango Therapeutics, Cellestia Biotech, LAVA Therapeutics N.V., Xencor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HaemaLogiX Ltd and Apitope are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HaemaLogiX Ltd, https://bouncewatch.com/company/haemalogix-ltd, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes